Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Crandell Keith
Relationship:   Director, 10% Owner
City:   Chicago
State:   IL
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   14,726,492    

Indirect Shares

  20,997,912      
Direct Value   $341,415,358    

Indirect Value

  $402,449,921      
Total Shares   35,724,404      
Total Value   $743,865,279      


Illumina Inc
 $669,790 Agios Pharmaceuticals Inc
 $140,299,219 Adesto Technologies Corp
 $318,466 Phaserx, Inc.
 $2 Quanterix Corp
 $2,077,154 Twist Bioscience Corp
 $0 Denali Therapeutics Inc.
 $198,011,981 Karuna Therapeutics, Inc.
 $0 908 Devices Inc.
 $38,745 Illumina Inc
 $669,790 Agios Pharmaceuticals Inc
 $140,299,219 Adesto Technologies Corp
 $318,466 Phaserx, Inc.
 $2 Quanterix Corp
 $2,077,154 Twist Bioscience Corp
 $0 Denali Therapeutics Inc.
 $198,011,981 Karuna Therapeutics, Inc.
 $0 908 Devices Inc.
 $38,745
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -35.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Illumina Inc ILMN Former 10% Holder 2004-02-03 6,423 2004-02-03 2,915,298    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2004-05-27 222,500    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 2004-03-19 0 2004-03-19 2,054,271    Premium*  
            Agios Pharmaceuticals Inc AGIO 10% Owner 2013-07-29 3,860,738 2013-07-29 0    Premium*  
            Adesto Technologies Corp IOTS Director 2019-06-04 25,396 2015-10-30 2,276,511    Premium*  
            Xtera Communications, Inc. XCOM 10% Owner 0 2015-11-17 1,885,090    Premium*  
            Phaserx, Inc. PZRX 10% Owner 2016-05-23 10,048 2016-05-23 2,854,222    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 10% Owner 2017-08-01 0 2017-08-01 882,493    Premium*  
            Quanterix Corp QTRX 2023-01-03 130,066 2021-11-18 0    Premium*  
            Twist Bioscience Corp TWST 2024-02-06 18,004 2022-02-08 76,047    Premium*  
            Denali Therapeutics Inc. DNLI 10% Owner 2019-08-08 10,668,749 2019-08-08 0    Premium*  
            Karuna Therapeutics, Inc. KRTX 10% Owner 2021-04-13 918 2021-04-13 1,456,435    Premium*  
            908 Devices Inc. MASS 2023-06-14 6,150 2023-06-14 5,725,045    Premium*  
            Da32 Life Science Tech Acquisiti... DALS Director, 10% Owner 2021-07-30 0 2023-07-28 650,000    Premium*  
* Premium Members only  

Records found :    102         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TWST Twist Bioscience Corp   –       •      –    2020-08-18 4 A $0.00 $0 I/I 34,848 34,848 0 -
TWST Twist Bioscience Corp   –       •      –    2020-09-02 4 D $0.00 $0 I/I (717,673) 485,422 0 -
TWST Twist Bioscience Corp   –       •      –    2020-09-02 4 A $0.00 $0 I/I 25,264 60,112 0 -
TWST Twist Bioscience Corp   –       •      –    2020-09-15 4 A $0.00 $0 I/I 22,580 82,692 0 -
TWST Twist Bioscience Corp   –       •      –    2020-09-15 4 D $0.00 $0 I/I (620,261) 309,392 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2020-11-12 4 D $0.00 $0 I/I (150,000) 1,606,435 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2020-11-12 4 A $0.00 $0 D/D 1,264 306 0 -
QTRX Quanterix Corp Director   –       •       •   2020-11-20 4 A $0.00 $0 D/D 854 10,925 0 -
QTRX Quanterix Corp Director   –       •       •   2020-11-20 4 D $0.00 $0 I/I (375,000) 1,391,690 0 -
QTRX Quanterix Corp Director   –       •       •   2020-11-24 4 A $0.00 $0 D/D 1,034 11,959 0 -
QTRX Quanterix Corp Director   –       •       •   2020-11-24 4 D $0.00 $0 I/I (454,434) 1,214,770 0 -
MASS 908 Devices Inc. Director   –       •       •   2020-12-22 4 A $0.00 $0 I/I 5,425,045 5,425,045 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2021-01-08 4 D $0.00 $0 I/I (150,000) 1,531,435 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2021-01-08 4 A $0.00 $0 D/D 1,264 612 0 -
TWST Twist Bioscience Corp   –       •       •   2021-02-03 4 A $0.00 $0 D/D 486 1,898 0 -
TWST Twist Bioscience Corp Director   –       •      –    2021-02-11 4 A $0.00 $0 I/I 14,561 97,253 0 -
TWST Twist Bioscience Corp Director   –       •      –    2021-02-11 4 D $0.00 $0 I/I (400,000) 174,584 0 -
QTRX Quanterix Corp Director   –       •      –    2021-03-09 4/A A $0.00 $0 D/D 13,643 28,069 0 -
QTRX Quanterix Corp Director   –       •      –    2021-03-09 4/A D $0.00 $0 I/I (425,000) 1,049,310 0 -
QTRX Quanterix Corp Director   –       •      –    2021-03-12 4/A A $0.00 $0 D/D 13,644 41,713 0 -
QTRX Quanterix Corp Director   –       •      –    2021-03-12 4/A D $0.00 $0 I/I (425,000) 883,850 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2021-04-13 4 A $0.00 $0 D/D 1,264 918 0 -
KRTX Karuna Therapeutics, Inc. 10% Owner   –       –       •   2021-04-13 4 D $0.00 $0 I/I (150,000) 1,456,435 0 -
TWST Twist Bioscience Corp Director   –       •      –    2021-05-13 4 D $0.00 $0 I/I (300,000) 89,412 0 -
QTRX Quanterix Corp Director   –       •      –    2021-05-13 4 A $0.00 $0 D/D 11,237 53,161 0 -

  102  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed